The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
ESOT is hosting an online workshop on 9 December from 18:00 to 19:30 to explore complex clinical scenarios in the management of CMV infection in solid organ transplantation. CMV continues to present significant challenges for transplant teams, particularly in cases that fail to respond to therapy or are complicated by co morbidities. The session brings
ESOT is proud to launch a new webinar series as part of its ongoing awareness campaign on Chronic Lung Allograft Dysfunction (CLAD) — the leading post-transplant complication limiting long-term survival after lung transplantation. This three-part series will cover: Clinical gaps and diagnostic challenges Patient perspectives Upcoming CLAD Guidelines and new educational tools First Webinar Chronic
ESOT is excited to announce the release of the second EURO-KEP newsletter, marking another important step towards a more connected and collaborative approach to kidney exchange in Europe. The EURO-KEP project, proudly supported by ESOT, is working to establish a sustainable cross-border kidney exchange programme that enhances opportunities for living donation and improves equity in
We’re thrilled to announce that the LEOPARD Project has released its first newsletter — a key milestone in our shared mission to transform liver transplantation across Europe. Backed by the EU’s Horizon Europe programme, LEOPARD is developing a next-generation digital platform to make liver allocation smarter, faster, and more equitable. By integrating artificial intelligence, real-time
The presence of anti-human leukocyte antigen (anti-HLA) antibodies defines transplant candidates as sensitised, a condition that affects access to transplantation, increasing waiting times and mortality rates. Following transplantation, sensitised patients have higher risk of antibody-mediated rejection (AMR) and graft failure when their anti-HLA antibodies are specific to the donor (DSA). Not all DSAs are equally
